Speak directly to the analyst to clarify any post sales queries you may have.
Senior decision-makers evaluating the multimodal imaging market face a shifting landscape driven by integration of advanced technologies and increasingly diverse clinical applications. The sector calls for agile strategic planning, as leaders seek to align growth, precision, and efficient clinical workflows in a rapidly evolving healthcare environment.
Market Snapshot: Growth Outlook for the Multimodal Imaging Market
The multimodal imaging market is demonstrating steady growth with revenues rising from USD 3.00 billion in 2024 to USD 3.19 billion in 2025. A compound annual growth rate (CAGR) of 6.37% is projected to push the market value to USD 4.92 billion by 2032. Driven by demands for improved diagnostic accuracy, greater use of hybrid imaging systems, and the expansion of personalized medicine initiatives, market participants are adopting comprehensive, integrated technologies. These solutions offer broader clinical insights and facilitate more informed treatment decisions. Progress is further enabled by continual improvements in imaging hardware and software, expanded clinical endpoints, and an increased focus by healthcare organizations on delivering better patient results through optimized workflows.
Scope & Segmentation: In-Depth Insights on Technologies, Applications, and Regions
This report provides executives with a comprehensive analysis of the multimodal imaging sector, allowing for targeted resource allocation and strategic planning. Segmentation addresses not just major technology components but also evolving clinical, geographical, and competitive shifts shaping the sector. The insights enable benchmarking, risk mitigation, and identification of untapped opportunities across the entire value chain.
- Component: The analysis covers hardware, software, and services, representing all aspects from development to ongoing operational support in the market.
- Imaging Modality: PET CT, PET MR, and SPECT CT are profiled, each contributing high-resolution, multidimensional data critical to modern diagnostics.
- Application: Solutions are evaluated in cardiovascular, neurology, and oncology settings, highlighting their impact in addressing complex clinical needs and supporting outcome measurement.
- End User: Distinct approaches are considered for academic institutes, diagnostic imaging centers, hospitals, and research institutions, reflecting varied integration requirements and support models.
- Region: Strategy insights span regional markets across the Americas, Europe, Middle East & Africa, and Asia-Pacific. These include developed economies as well as emerging markets with unique infrastructure and workforce priorities.
- Leading Companies: Key players in the competitive landscape include General Electric Company, Siemens Healthineers AG, Koninklijke Philips N.V., Canon Medical Systems Corporation, Fujifilm Holdings Corporation, PerkinElmer, Inc., Bruker Corporation, United Imaging Healthcare Co., Ltd., Mediso Medical Imaging Systems Ltd., and MR Solutions Ltd.
Key Takeaways: Strategic Insights for Decision-Makers
- Adoption of hybrid scanners and integrated imaging protocols is accelerating, which supports improved clinical diagnostics and more efficient patient management processes.
- Artificial intelligence and machine learning now form a vital part of image analysis, driving progress in early disease identification and supporting predictive analytics for population health strategies.
- Collaboration among manufacturers, academic centers, and pharmaceutical companies is advancing innovation, particularly in tracer development and biomarker standardization, expanding both clinical and research use cases.
- Organizations are prioritizing operational resilience, building adaptability to respond quickly to policy shifts and supply chain disruptions as a core strategic objective.
- Regional market differences are notable; established economies focus on clinical trials and technology advancements, while developing areas invest in upgrading health infrastructure, workforce capabilities, and fostering public-private partnerships.
- Demand is growing for comprehensive service bundles that combine technical equipment, analytics platforms, and ongoing training. This trend reflects a transition to value-based, outcome-oriented partnerships over one-time product transactions.
Tariff Impact: Adjusting Strategy in Response to U.S. Policy Shifts
Recent tariffs applied to U.S. imports of imaging components are impacting procurement and introducing fresh cost structures in the multimodal imaging market. In response, manufacturers are increasing local supplier engagement, investing in domestic production, and diversifying strategic partnerships to manage tariff risks. Health systems are also reassessing expenditures, favoring service models that improve asset utilization and maintain flexibility in a changing regulatory environment.
Methodology & Data Sources
This report is based on a blend of qualitative and quantitative analysis. Methods include review of peer-reviewed literature, interviews with industry experts in radiology and technology, corporate filings, and regulatory disclosures. Data modeling integrates both primary and secondary inputs, ensuring strategic recommendations are accurate and credible.
Why This Report Matters
- Equips leaders to benchmark strategy in hybrid imaging and artificial intelligence acceleration, supporting informed investments and competitive positioning.
- Provides data-driven segmentation, actionable recommendations for regional planning, and supply chain resilience insights.
- Guides long-term decision-making with up-to-date intelligence on top companies, sector innovation, and regulatory trends.
Conclusion
Ongoing advances in multimodal imaging, collaborative innovation, and evolving service models are reshaping executive decisions in this market. Leaders can use these insights to refine strategy, strengthen key partnerships, and safeguard sustainable growth in a complex regulatory and technological environment.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
List of Figures
Samples

LOADING...
Companies Mentioned
The key companies profiled in this Multimodal Imaging market report include:- General Electric Company
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Fujifilm Holdings Corporation
- PerkinElmer, Inc.
- Bruker Corporation
- United Imaging Healthcare Co., Ltd.
- Mediso Medical Imaging Systems Ltd.
- MR Solutions Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 198 |
| Published | October 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 3.19 Billion |
| Forecasted Market Value ( USD | $ 4.92 Billion |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |


